Search results
Lilly drug for Alzheimer’s approved by FDA
BioPharma Dive· 5 days agoThe drug, which Lilly will sell as Kinsunla, carries a warning for the risk of a certain kind of imaging abnormality that can be serious in rare cases.
'There can be safety concerns.' Sympathy, caution from Cape Codders after Riviello death
Cape Cod Times· 6 days ago"What can happen for people living with cognitive loss is they can get confused, and there can be...
FSSAI cancels manufacturing licences of 111 spice producers across India | - Times of India
The Times of India· 6 days agoIn the month of April, Singapore and Hong Kong banned the sale of popular Indian spice brands MDH...